|
"Enhancement of Brain Tumor Immunotherapy by Fas-L RNAi"
|
4R33CA112148-03
|
$348,323
|
Olivi, Alessandro
|
JOHNS HOPKINS UNIVERSITY
|
|
33rd International Herpesvirus Workshop
|
2R13CA102553-06
|
$5,000
|
NELSON, JAY
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
A Mouse Model for Prostate Cancer
|
7U01CA084294-10
|
$1,446,104
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
A Novel Inhibitor of Stat3 for Prostate Cancer Therapy
|
5R01CA104035-04
|
$280,899
|
JING, NAIJIE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Activity & resistance of Gleevec in GI stromal tumors
|
5K23CA109060-05
|
$136,080
|
TRENT, JONATHAN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
Z01 BC 010984
|
$1,116,265
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Adrenocortical Cancer and Thyroid Carcinomas: Models with Unique Properties
|
Z01 BC 010626
|
$388,228
|
Fojo, Antonio
|
CCR (NCI)
|
|
ALL Fusion Proteins: Associated with Multi-protein Complexes and Role in Transcri
|
5R01CA128609-03
|
$300,246
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
|
ALPHAV INTEGRINS AND TUMOR ANGIOGENESIS
|
5R37CA050286-20
|
$446,134
|
CHERESH, DAVID
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Altered Proteoglycan Gene Expression and Cancer
|
5R01CA039481-23
|
$374,657
|
IOZZO, RENATO
|
THOMAS JEFFERSON UNIVERSITY
|
|
Analyzing Hepatitis B Virus Pathogenesis
|
5R01CA023931-30
|
$325,985
|
Isom, Harriet
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Antiangiogenic Gene Therapy of Ovarian and Breast Cancers
|
5R01CA114340-02
|
$253,417
|
RAMAKRISHNAN, SUNDARAM
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Antibody Neutralization of Therapeutic Viruses
|
1R01CA129966-01A1
|
$486,003
|
RUSSELL, STEPHEN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
AP-1 Complexes and Target Gene Regulation
|
5R01CA114381-03
|
$256,204
|
TAPAROWSKY, ELIZABETH
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
|
ARHI (NOEY2), an imprinted breast cancer suppressor gene
|
5R01CA080957-08
|
$176,064
|
YU, YINHUA
|
FUDAN UNIVERSITY
|
|
Armed Replicating Ad for Breast Cancer Bone Metastasis
|
5R01CA108585-03
|
$225,695
|
Douglas, Joanne
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Astrocytic Cancers: How, When, Where?
|
5U01CA084314-10
|
$976,583
|
VAN DYKE, TERRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-19
|
$481,201
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Biodegradable Polymers For DNA Vaccine Delivery
|
1R01CA129189-01A1
|
$304,088
|
WANG, CHUN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Biological and genetic analysis of Fish, a Src substrate
|
5R01CA098383-06
|
$334,133
|
COURTNEIDGE, SARA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Biology & Transplantation of the Human Stem Cell
|
5P01CA065493-14
|
$2,080,053
|
MCGLAVE, PHILIP
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Bone Marrow Transplantation in Human Disease
|
5P01CA015396-33
|
$2,910,583
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
BRAIN TUMOR SPORE GRANT
|
5P50CA097257-07
|
$2,327,870
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Breast Cancer Biology of Translational De-repression
|
5R01CA063640-12
|
$237,241
|
HAGEDORN, CURT
|
UNIVERSITY OF UTAH
|
|
Cancer and Leukemia Group B
|
5U10CA037447-25
|
$1,580,095
|
SCHILSKY, RICHARD
|
UNIVERSITY OF CHICAGO
|
|
Cancer dual-targeting of an infectivity-enhance CRAd
|
2R42CA114921-02A2
|
$412,501
|
MATHIS, J
|
VECTORLOGICS, INC.
|
|
Cancer Education Program
|
5R25CA020449-31
|
$264,718
|
Fahey, Thomas
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Cancer Gene Therapy Training Program
|
5T32CA075930-10
|
$183,164
|
Curiel, David
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Cancer-Related Glycolytic Gene:Regulation and Targeting
|
5R01CA080118-10
|
$232,542
|
PEDERSEN, PETER
|
JOHNS HOPKINS UNIVERSITY
|
|
Carbocyclic Nucleoside Isosteres as Potential Antitumor and Antiviral Agents
|
Z01 BC 006174
|
$190,292
|
Marquez, Victor
|
CCR (NCI)
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-10
|
$537,840
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cell Prep Core
|
Z01 BC 010905
|
$868,123
|
Wunderlich, John
|
CCR (NCI)
|
|
Cell Production Facility Core
|
Z01 BC 011020
|
$868,123
|
Dudley, Mark
|
CCR (NCI)
|
|
Cell Therapy of Refractory Leukemia
|
5R01CA113482-03
|
$286,536
|
CAMPANA, DARIO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cellular co-factors in stable retroviral transduction
|
5R01CA125272-02
|
$235,600
|
DANIEL, RENE
|
THOMAS JEFFERSON UNIVERSITY
|
|
Cellular Transduction with Replication-Competent Retrovirus Vectors
|
5R01CA121258-02
|
$467,899
|
KASAHARA, NORIYUKI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Center for Molecular Imaging Research at MGH/HMS
|
5P50CA086355-09
|
$1,575,134
|
WEISSLEDER, RALPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Characteristics of Multidrug Resistance in Human Tumors
|
5R01CA040570-21
|
$261,339
|
BECK, WILLIAM
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Chitosan-plasmid DNA nanoplexes and adenoviruses as prostate cancer vaccines
|
1R21CA133456-01
|
$168,750
|
SALEM, ALIASGER
|
UNIVERSITY OF IOWA
|
|
Chronic Lymphocytic Leukemia Research Consortium
|
5P01CA081534-09
|
$3,860,269
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
City of Hope Lymphoma SPORE
|
5P50CA107399-05
|
$2,163,322
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Clinical and Laboratory Studies of Malignant Lymphomas
|
5P01CA034233-24
|
$1,681,253
|
LEVY, RONALD
|
STANFORD UNIVERSITY
|
|
Clinical Scholars Biomedical Research Training Program
|
5T32CA009512-23
|
$258,708
|
KELLY, THOMAS
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Clinical study of AdV-tk radiogene therapy for malignant glioma
|
5R44CA107745-04
|
$794,415
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
Combination gene therapy for metastatic colon cancer
|
5R01CA070337-12
|
$287,106
|
CHEN, SHU-HSIA
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Combinatorial Chemistry and Cancer Target
|
5P01CA078045-10
|
$1,341,169
|
VOGT, PETER
|
SCRIPPS RESEARCH INSTITUTE
|
|
Combining Virotherapy and Immunotherapy for Cancer
|
5R01CA105171-05
|
$300,313
|
KASAHARA, NORIYUKI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Community Clinical Oncology Program
|
2U10CA035199-25
|
$484,645
|
GRINBLATT, DAVID
|
EVANSTON NORTHWESTERN HEALTHCARE
|
|
Conditionally Replicative Adenoviral Vectors for Malignant Glioma
|
1R01CA122930-01A2
|
$323,817
|
LESNIAK, MACIEJ
|
UNIVERSITY OF CHICAGO
|
|
Control of Protein Translation in Cancer Pathogenesis
|
7U01CA084292-10
|
$697,531
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|